GSAおよびベネルクスのPOCT市場規模、シェア、トレンド分析レポート
Market Size in USD Billion
CAGR :
% 
USD
3.63 Billion
USD
9.07 Billion
2024
2032
 予測期間 |
2025 –2032 |
 市場規模（基準年） |
USD 3.63 Billion |
 Market Size (Forecast Year) |
USD 9.07 Billion |
 CAGR |
% |
| Major Markets Players |
|
GSAおよびベネルクスのPOCT（ポイントオブケア検査）市場、製品タイプ別（血糖モニタリング製品、感染症検査製品、心血管代謝モニタリング製品、妊娠および不妊検査製品、血液学検査製品、凝固モニタリング製品、乱用薬物（DOA）検査製品、尿検査製品、コレステロール検査製品、腫瘍/がんマーカー検査製品、便潜血検査製品、その他）、プラットフォーム別（ラテラルフローアッセイ/免疫クロマトグラフィー検査、免疫アッセイ、ディップスティック、分子診断、臨床化学アッセイ、マイクロフルイディクス、血液学、その他）、用途別（血糖値、感染症、バイタルサインモニタリング、心臓モニタリング、凝固、血液学、非侵襲性SpO2モニタリング、輸血、非侵襲性PCO2モニタリング、全血分析、その他）、処方モード別（処方箋に基づく検査、市販の検査）、エンドユーザー別（病院、在宅ケア、診療所、検査室、診断センター、病理学ラボ、外来手術センター、高齢者ケアセンター、その他）、流通チャネル別（直接入札、小売販売、オンライン販売、その他） - 2032年までの業界動向と予測
ポイントオブケア検査（POCT）市場規模
- GSA Point-of-Care Testing (POCT)市場規模は2024年に36億3000万米ドルと評価され、予測期間中に12.1%のCAGRで成長し、2032年までに90億7000万米ドルに達すると予想されています。
- ベネルクスのポイントオブケア検査（POCT）市場規模は2024年に8億8,200万米ドルと評価され、予測期間中に9.5％のCAGRで成長し、2032年には18億1,900万米ドルに達すると予想されています。
- この成長は、迅速な診断結果に対する需要の高まり、慢性疾患や感染症の増加、ポータブル診断技術の進歩などの要因によって推進されています。
ポイントオブケア検査（POCT）市場分析
- ポイントオブケア検査（POCT）機器は、患者のケア現場またはその近くで迅速な診断結果を提供する上で重要な役割を果たし、様々な医療現場における臨床意思決定を大幅に向上させます。これらの検査は、慢性疾患、感染症、救急医療の管理に広く利用されています。
- GSAおよびベネルクス地域におけるPOCTソリューションの需要は、主に慢性疾患の負担の増加、高齢者人口の増加、分散型で患者中心の医療モデルの強い推進によって推進されています。
- ドイツは、確立された医療インフラ、高い診断スループット、先進医療技術の導入により、この地域でPOCT市場を28.04%のシェアで支配すると予想されています。
- ベネルクス諸国は、政府の好ましい取り組み、医療費の増加、臨床環境と在宅ケア環境の両方でのPOCTの採用の増加により、市場の大幅な成長が見込まれています。
- 血糖値検査セグメントは34.08%のシェアを占め、糖尿病の罹患率の高さと、患者の病気管理を支援するリアルタイムモニタリングツールの需要に牽引され、この地域のPOCT市場をリードすると予想されています。
レポートの範囲とポイントオブケア検査（POCT）市場のセグメンテーション
|
属性 |
眼科手術顕微鏡の主要市場分析 |
|
対象セグメント |
|
|
対象国 |
GSA
ベネルクス
|
|
主要な市場プレーヤー |
|
|
市場機会 |
|
|
付加価値データ情報セット |
データブリッジマーケットリサーチがまとめた市場レポートには、市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、輸出入分析、生産能力概要、生産消費分析、価格動向分析、気候変動シナリオ、サプライチェーン分析、バリューチェーン分析、原材料/消耗品概要、ベンダー選択基準、PESTLE分析、ポーター分析、規制枠組みも含まれています。 |
ポイントオブケア検査（POCT）市場動向
「GSAとベネルクスにおける迅速診断と分散型検査の進歩」
- GSAおよびベネルクス地域のPOCT市場を形作る顕著なトレンドの1つは、デジタル接続、小型センサー、およびポイントオブケアデバイスにおけるマルチプレックス検査機能の統合の増加です。
- これらのイノベーションにより、診断のスピードと精度が向上し、医療従事者は、特に救急現場、慢性疾患の管理、感染症のスクリーニングにおいて、タイムリーな判断を下すことができます。
- 例えば、ワイヤレスデータ伝送と電子健康記録（EHR）統合を備えたPOCTシステムは、患者のモニタリングを効率化し、病院への訪問を減らすために、ドイツとオランダのプライマリケアの現場でますます使用されています。
- これらの進歩は、分散型診断に革命をもたらし、価値に基づくケアモデルをサポートし、GSAおよびベネルクス地域全体で患者中心の医療への移行を加速させています。
- 予防医療への重点の高まりと、疾病の早期発見に対する政府の強力な支援が相まって、分析性能と使いやすさが向上した次世代POCTソリューションの需要が高まり続けています。
ポイントオブケア検査（POCT）市場の動向
ドライバ
「医療施設におけるPOC検査の利用増加」
- 医療施設におけるポイントオブケア（POC）検査の利用増加は、医療従事者が病気を診断し管理する方法に革命をもたらしている。
- 迅速かつ正確な診断結果へのニーズが高まる中、医療従事者は患者ケアの質を向上させるためにPOC検査に注目しています。この変化は、迅速な意思決定が不可欠な救急室、外来診療所、診断センターにおいて特に顕著です。
- POC検査により、医療従事者はケアの現場で即座に結果を得ることができ、患者が検査結果を待つ必要がなくなり、診断と治療までの時間が大幅に短縮されます。
- さらに、POC検査は持ち運びやすく、ユーザーフレンドリーであるため、地方の診療所から大規模な病院まで、さまざまな医療現場での使用に最適です。
- 慢性疾患の増加と効率的なヘルスケアソリューションの需要の高まりにより、特に糖尿病、心血管疾患、感染症などの疾患のモニタリングを向上させるPOC検査の導入がさらに促進されています。
- 医療施設がこれらの技術をワークフローに取り入れるケースが増えているため、ポイントオブケア検査の需要は増加し続けており、市場拡大の重要な推進力となっています。
例えば、
- NCBIによると、2024年3月時点で、POCTの迅速な処理時間は、特に救急部門（ED）において、臨床意思決定の強化、管理時間の短縮、トリアージ効率の向上をもたらします。その柔軟性は、病院前、野戦病院、災害時、大規模集会、または過密地域などにも及びます。
- 2024年11月、OBJECTIVE Investment Banking & Valuationが発表した記事によると、ポイントオブケア検査（POCT）への移行は、患者のケア現場に直接診断をもたらすことで医療に革命をもたらしました。そのスピード、利便性、そして効率性は、救急、外来、そして遠隔地の現場で非常に貴重です。迅速診断の需要が高まるにつれて、
- 医療施設におけるポイントオブケア（POC）検査の導入拡大は、疾患の診断と管理に変革をもたらしています。迅速かつ正確な結果を求める医療従事者は、患者ケアの向上にPOC検査を活用しています。
機会
「ポイントオブケア検査への意識と支持の高まり」
- 医療専門家、政策立案者、一般の人々が、迅速な結果、患者管理の改善、ターンアラウンドタイムの短縮、分散検査の可能性など、POCTの利点についてより深く理解するにつれて、これらのソリューションに対する需要が高まっています。
- 患者団体、専門機関、業界団体による支援活動により、救急科、プライマリケア、さらには地域社会を含むさまざまな臨床現場でのPOCTの価値がさらに強調されています。
- この理解とサポートの増加は、POCTへの投資と既存の医療ワークフローへの統合に対する意欲の高まりにつながり、採用と利用の増加を促進することで市場規模と範囲を拡大します。
例えば、
- 2023年4月、NCBIはドイツの一般開業医（GP）の圧倒的多数、驚くべきことに93%が、POCT（Point-of-Care Tests）を診療における有用な診断ツールと認識していると発表した。彼らは主に、患者管理に関する迅速な意思決定と診断の確実性の向上をPOCT活用の主な利点として挙げている。
- Open Repositoryに掲載された「オランダのプライマリケアにおけるポイントオブケア検査」という記事によると、医療従事者は治療上の意思決定においてポイントオブケア（POC）診断検査をますます活用するようになっている。これらの検査の主な利点は、患者のいる場所またはその近くで迅速に結果を提供できることである。
- さらに、こうした意識向上と支援活動は、POCTのより広範な導入を支援する好ましい政策変更や資金提供の取り組みにつながる可能性があります。GSAとベネルクスの政府と医療制度は、POCTが診断の効率性とアクセスを向上させる可能性を認識し、これらの技術の導入に向けてより多くの資源を配分する可能性があります。
- アドボカシー活動は、規制当局に働きかけ、革新的なPOCT機器の承認プロセスを簡素化し、市場参入を加速させる効果もあります。これにより、市場の成長を促進する環境が整い、既存企業と新規参入企業の両方が、高まる需要に対応するための高度なPOCTソリューションの開発と導入に投資するよう促されます。
抑制/挑戦
「データセキュリティとプライバシーに関する懸念」
- POCTデバイスがデジタルプラットフォームと統合されるにつれ、患者の機密情報の収集、送信、保管は、不正アクセスやデータ漏洩のリスクを高めます。個人の医療情報を含む医療データは、HIPAAやGDPRなどの法律に基づく厳格な保護が求められており、メーカーや医療提供者にとってコンプライアンスの複雑さが増しています。
- 一部の POCT デバイスには堅牢なセキュリティ フレームワークと暗号化プロトコルが欠如しているため、こうした懸念はさらに増大します。
- さらに、プライバシーリスクを理由に患者が医療データを共有することに躊躇することは、特にデジタルヘルスソリューションへの信頼が限られている地域では、普及の妨げとなる可能性があります。安全でプライバシーに準拠したシステムの継続的な開発は不可欠ですが、現在の懸念は制約となり、GSAおよびベネルクスPOCT市場におけるイノベーションと普及のペースを鈍化させています。
例えば、
- MDPIが2021年7月に公開したブログによると、サイバーセキュリティとプライバシーのリスクに関して考慮すべき重要な点の1つは、病院で広く利用されている医療現場のPOC（Point-of-Care）システムです。POCシステムは、データを収集、処理、可視化するためにデバイスとアプリケーションを統合したプラットフォームです。個人の健康情報や機密性の高い医療データを含む大量のデータが、様々なPOCシステム、バックエンド分析プラットフォーム、ユーザーワークステーション、スマートフォンを介して通信されることで、患者の生命に危害を及ぼすデータ漏洩や侵害インシデントを引き起こす複数の脅威が存在することが明らかになっています。POC検査はデータ漏洩に対して脆弱であり、これが市場の成長を阻害する要因となっています。
- データセキュリティとプライバシーへの懸念は、GSAおよびベネルクスのPOCT（Point-of-Care Testing）市場における大きな課題です。デジタルプラットフォームに接続するデバイスが増えるにつれて、特に患者の機密情報に関する不正アクセスやデータ漏洩のリスクが高まります。HIPAAやGDPRなどの規制への準拠は、メーカーや医療提供者にとって複雑さを増します。一部のデバイスに強固なセキュリティが備わっていないことや、患者のプライバシーに関する懸念は、特にデジタルヘルスソリューションへの信頼が低い地域では、導入を遅らせる可能性があります。これらの障壁を克服するには、安全でプライバシーに準拠したシステムの開発が不可欠です。
ポイントオブケア検査（POCT）市場の範囲
市場は、アプリケーション、製品タイプ、テクノロジー、拡大タイプ、エンドユーザー、流通チャネルに基づいてセグメント化されています。
|
セグメンテーション |
サブセグメンテーション |
|
製品タイプ別 |
|
|
プラットフォーム別 |
|
|
アプリケーション別 |
|
|
処方箋モード
|
|
|
エンドユーザー別 |
|
|
流通チャネル別
|
|
2025年には、血糖値モニタリング製品が製品タイプセグメントで最大のシェアを占め、市場を支配すると予測されています。
糖尿病の罹患率が高く、便利で即時の血糖値検査が頻繁に必要とされることから、血糖値モニタリング製品セグメントは、2025年に34.08%の最大シェアでポイントオブケア検査（POCT）市場を 支配すると予想されています。
ラテラルフローアッセイ/免疫クロマトグラフィー検査は、予測期間中にプラットフォームセグメントで最大のシェアを占めると予想されます。
2025年には、ラテラルフローアッセイ/免疫クロマトグラフィー検査セグメントが、そのシンプルさ、迅速な結果、費用対効果、そして従来の実験室環境以外の幅広い診断アプリケーションへの適合性により、37.28%の最大市場シェアで市場を支配すると予想されています。
ポイントオブケア検査（POCT）市場の地域分析
「ドイツはポイントオブケア検査（POCT）市場で最大のシェアを握っている」
- ドイツは、高度に発達した医療インフラ、革新的な診断技術の広範な導入、予防医療と個別化医療への強い重点により、GSA地域内で82.06%のシェアでポイントオブケア検査（POCT）市場を支配しています。
- 特に糖尿病、心血管疾患、呼吸器感染症などの慢性疾患の管理において、迅速かつ正確な診断ソリューションに対する需要が高まっているため、この国は大きなシェアを占めています。
- 支援的な償還枠組み、政府が支援するデジタルヘルスイニシアチブ、ヘルスケア研究開発への強力な投資が市場の成長をさらに後押しする
- さらに、救急科、プライマリケア、在宅医療におけるPOCTの導入の増加と、病院の負担軽減への重点が相まって、ドイツ全土で市場拡大を促進しています。
「オランダは、ポイントオブケア検査（POCT）市場において最も高いCAGRを記録すると予測されています」
- オランダは、デジタルヘルスケア、早期疾患検出、患者中心のケアモデルに重点を置いており、ポイントオブケア検査（POCT）市場で54.40%のシェアを獲得し、堅調な成長が見込まれています。
- 国の人口の高齢化と糖尿病、心血管疾患、呼吸器疾患などの慢性疾患の増加により、迅速かつ分散型の診断ソリューションの需要が高まっています。
- オランダは、確立されたプライマリケアシステムと進歩的な医療政策により、特に地域医療現場、一般開業医（GP）クリニック、在宅ケアサービスにおいて、POCT技術の重要な導入国であり続けています。
- POCTデバイスと電子健康記録（EHR）の統合の増加、医療保険会社による診断技術革新への支援、EU全体の医療技術イニシアチブへの積極的な参加により、市場の見通しはさらに強化されています。
- 学術機関、テクノロジー系スタートアップ、診断企業間の連携により、オランダの医療システムに合わせた先進的でユーザーフレンドリーなPOCTソリューションのイノベーションと現地開発が加速しています。
ポイントオブケア検査（POCT）市場シェア
市場競争環境は、競合他社ごとに詳細な情報を提供します。企業概要、財務状況、収益、市場ポテンシャル、研究開発投資、新規市場への取り組み、グローバルプレゼンス、生産拠点・設備、生産能力、強みと弱み、製品投入、製品群の幅広さ、アプリケーションにおける優位性などの詳細が含まれます。上記のデータは、各社の市場への注力分野にのみ関連しています。
市場で活動している主要なマーケットリーダーは次のとおりです。
- F. ホフマン・ラ・ロシュ社（スイス）
- ダナハーコーポレーション（米国）
- シーメンス・ヘルシニアーズAG（ドイツ）
- バイオ・ラッド・ラボラトリーズ社（米国）
- ビオメリュー（フランス）
- BD（米国）
- クイデルオルソコーポレーション（米国）
- ホロジック社（米国）
- サーモフィッシャーサイエンティフィック社（米国）
- アボット（米国）
- ヴェルフェン（スペイン）
- QIAGEN（ドイツ）
- シスメックス株式会社（日本）
- EKF Diagnostics Holdings plc.（英国）
- セキスイ・ダイアグノスティクス（米国）
- メリディアン・バイオサイエンス（米国）
- ビンクスヘルス社（米国）
- トリニティ・バイオテック（アイルランド）
- Sienco, Inc.（米国）
- ACCUBIOTECH CO., LTD.（中国）
GSAおよびベネルクスのPOCT（ポイントオブケア検査）市場の最新動向
- ロシュは2023年12月、LumiraDxの革新的なPoint of Care技術の一部を買収し、診断ポートフォリオを強化しました。この買収により、複数の疾患領域において、より迅速で手頃な価格の検査が可能になります。LumiraDxのプラットフォームとの統合により、世界中の分散型医療現場において、患者がタイムリーかつ正確な診断結果にアクセスしやすくなります。
- 2025年1月、ダナハー・コーポレーションはヘルスケアAI企業であるイノバッカー社と投資提携を締結しました。この提携は、医療従事者に統合された患者データと高度な分析を提供し、個別化されたタイムリーな介入を通じて患者の転帰を改善することで、精密診断と価値に基づくケアの導入を加速させることを目指しています。
- ビオメリューは2024年10月、抗菌薬耐性（AMR）に関する世界的な課題の推進のため、多部門連携を呼びかけました。同社は、AMR対策において、医療、政府、産業界の連携が緊急に必要であることを強調し、革新的な診断ソリューションと責任ある抗菌薬の使用を推進することで、この深刻化する世界的な健康脅威に対抗していきます。
- 2024年3月、バイオ・ラッドは、迅速かつ正確な食品安全試験を実現するXP-Designアッセイ サルモネラ血清型判定ソリューションを発売しました。XP-Designアッセイ サルモネラ血清型判定ソリューションは、初期スクリーニング後にサルモネラ菌の血清型を同定するための柔軟なアプローチを提供します。すぐに使用できるこのソリューションには、標的血清型に特異的なオリゴヌクレオチド（プライマーとプローブ）が含まれており、高い特異性を保証するとともに交差反応のリスクを低減し、信頼性の高い結果をもたらします。
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 YEARS CONSIDERED FOR THE STUDY
2.3 CURRENCY AND PRICING
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 MULTIVARIATE MODELLING
2.6 PRODUCT TYPE LIFELINE CURVE
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 MARKET END USER COVERAGE GRID
2.1 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTAL ANALYSIS
4.2 PORTERS FIVE FORCES ANALYSIS
4.3 MICRO AND MACRO ECONOMIC FACTORS
4.4 PENETRATION AND GROWTH PROSPECT MAPPING
4.5 KEY PRICING STRATEGIES
4.6 COST ANALYSIS BREAKDOWN
4.7 OPPORTUNITY MAP ANALYSIS
4.8 VALUE CHAIN ANALYSIS
4.9 HEALTHCARE ECONOMY
4.1 TARIFFS
4.10.1 DEFINITION AND IMPORTANCE OF TARIFFS IN THE HEALTHCARE SECTOR
4.10.2 GLOBAL VS. REGIONAL TARIFF STRUCTURES
4.10.3 IMPACT OF TARIFFS ON HEALTHCARE COSTS AND ACCESSIBILITY
4.10.4 TARIFF REGULATIONS IN KEY MARKETS
4.10.4.1 MEDICARE/MEDICAID TARIFF POLICIES
4.10.4.2 CMS PRICING MODELS
4.10.4.3 OTHERS
4.10.5 TARIFFS ON MEDICAL DEVICES & EQUIPMENT
4.10.5.1 IMPORT/EXPORT DUTIES ON MEDICAL EQUIPMENT
4.10.5.2 IMPACT ON PRICING AND AVAILABILITY OF HIGH-END MEDICAL TECHNOLOGY
4.10.5.3 CASE STUDIES OF TARIFF CHANGES AFFECTING THE INDUSTRY
4.10.6 COST BURDEN ON HOSPITALS AND HEALTHCARE FACILITIES
4.10.7 TARIFF EXEMPTIONS AND INCENTIVES
4.10.8 DUTY-FREE IMPORTS FOR ESSENTIAL MEDICINES AND VACCINES
4.10.9 16.9 IMPACT OF TRADE WARS ON THE HEALTHCARE SUPPLY CHAIN
4.10.10 ROLE OF FREE TRADE AGREEMENTS (FTAS) IN REDUCING TARIFFS
5 CUSTOMIZATION
5.1 LEADING DIGITAL HEALTH PLATFORMS IN EACH COUNTRY –
5.2 POCT DATA INTEGRATION USE CASES –
5.3 INFORMATICS PLATFORMS & TELEMEDICINE INTEGRATION:
6 REGULATORY
6.1 REGULATORY GSA
6.2 REGULATORY BENELUX
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 RISING USE OF POC TESTING IN HEALTHCARE FACILITIES
7.1.2 RISING INCIDENCE OF SUBSTANCE ABUSE
7.1.3 INCREASED ADOPTION OF TELEMEDICINE
7.1.4 ADVANCEMENTS TECHNOLOGIES ENHANCING POC TESTING WITH BIOSENSORS AND MOBILE INTEGRATION
7.2 RESTRAINTS
7.2.1 DATA SECURITY AND PRIVACY CONCERNS
7.2.2 ACCURACY LIMITATIONS AND TECHNICAL BARRIERS
7.3 OPPORTUNITIES
7.3.1 RISING AWARENESS AND ADVOCACY FOR POINT-OF-CARE TESTING
7.3.2 STRATEGIC INITIATION AND DECISION TAKEN BY THE MARKET PLAYERS
7.3.3 EXPANDING PRODUCT RANGE FOR POINT-OF-CARE TESTING
7.4 CHALLENGES
7.4.1 LIMITED AWARENESS AND ACCEPTANCE OF POINT-OF-CARE (POC) TESTING
7.4.2 IMPACT OF HIGH MAINTENANCE COSTS THREATEN POINT-OF-CARE TESTING (POCT) SUSTAINABILITY IN LOW-RESOURCE SETTINGS
8 GSA POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 GLUCOSE MONITORING PRODUCTS
8.2.1 STRIPS
8.2.2 METERS
8.2.3 LANCETS AND LANCING DEVICES
8.3 INFECTIOUS DISEASE TESTING PRODUCTS
8.3.1 COVID-19
8.3.2 HIV TESTING PRODUCTS
8.3.2.1 TESTING REAGENTS
8.3.2.2 TESTING EQUIPMENT
8.3.3 RESPIRATORY INFECTION TESTING PRODUCTS
8.3.4 SEXUALLY TRANSMITTED DISEASES (STD) TESTING
8.3.4.1 NAAT-BASED SYSTEMS
8.3.4.2 NON–NAAT-BASED SYSTEMS
8.3.5 HEPATITIS C TESTING PRODUCTS
8.3.5.1 HCV ANTIBODY TESTS
8.3.5.2 HCV VIRAL LOAD TESTS
8.3.6 INFLUENZA TESTING PRODUCTS
8.3.6.1 TRADITIONAL DIAGNOSTIC TEST
8.3.6.1.1 RAPID INFLUENZA DIAGNOSTIC TEST (RIDT)
8.3.6.1.2 DIRECT FLUORESCENT ANTIBODY TEST (DFAT)
8.3.6.1.3 VIRAL CULTURE
8.3.6.1.4 SEROLOGICAL ASSAY
8.3.6.2 MOLECULAR DIAGNOSTIC ASSAY
8.3.6.2.1 RT-PCR
8.3.6.2.2 LOOP-MEDIATED ISOTHERMAL AMPLIFICATION-BASED ASSAY (LAMP)
8.3.6.2.3 NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION TEST (NASBAT)
8.3.6.2.4 SIMPLE AMPLIFICATION-BASED ASSAY (SAMBA)
8.3.7 HEALTHCARE ASSOCIATED INFECTION (HAI) TESTING
8.3.8 TROPICAL DISEASE TESTING PRODUCTS
8.3.9 OTHER INFECTIOUS DISEASE TESTING PRODUCTS
8.4 CARDIOMETABOLIC MONITORING PRODUCTS
8.4.1 CARDIAC MARKER TESTING PRODUCTS
8.4.1.1 HSTNL
8.4.1.2 BNP
8.4.1.3 D-DIMER
8.4.1.4 CK-MB
8.4.1.5 MYOGLOBIN
8.4.2 BLOOD GAS/ELECTROLYTE TESTING PRODUCTS
8.4.3 BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES
8.4.3.1 CARTRIDGES
8.4.3.2 REAGENTS
8.4.4 BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS
8.4.4.1 PORTABLE
8.4.4.1.1 COMBINED ANALYZERS
8.4.4.1.2 BLOOD GAS ANALYZERS
8.4.4.1.3 ELECTROLYTE ANALYZERS
8.4.4.2 BENCHTOP
8.4.4.2.1 COMBINED ANALYZERS
8.4.4.2.2 BLOOD GAS ANALYZERS
8.4.4.2.3 ELECTROLYTE ANALYZERS
8.4.5 HBA1C TESTING PRODUCTS
8.4.5.1 HBA1C TESTING INSTRUMENTS
8.4.5.2 HBA1C TESTING CONSUMABLES
8.4.6 POC ANALYZER
8.4.7 ECG DEVICE
8.4.7.1 RESTING ECG DEVICES
8.4.7.2 STRESS ECG DEVICES
8.4.7.3 HOLTER MONITORS
8.5 PREGNANCY AND FERTILITY TESTING PRODUCTS
8.5.1 PREGNANCY TESTING PRODUCTS
8.5.1.1 STRIPS/ DIP STICKS AND CARDS
8.5.1.2 MID STREAM DEVICES
8.5.1.3 CASSETTES
8.5.1.4 DIGITAL DEVICES
8.5.1.5 LINE-INDICATOR DEVICES
8.5.2 FERTILITY TESTING PRODUCTS
8.5.2.1 LUTEINIZING HORMONE (LH) URINE TEST
8.5.2.2 FSH TEST
8.5.2.3 OTHERS
8.6 HAEMATOLOGY TESTING PRODUCTS
8.7 COAGULATION MONITORING PRODUCTS
8.7.1 ANTICOAGULATION MONITORING DEVICES
8.7.1.1 PROTHROMBIN TIME/INTERNATIONAL NORMALIZED RATIO (PT-INR) TESTING DEVICES
8.7.1.2 ACTIVATED CLOTTING TIME (ACT)
8.7.1.3 ACTIVATED PARTIAL THROMBOPLASTIN TIME (APPT)
8.7.2 PLATELET FUNCTION MONITORING DEVICES
8.7.3 VISCOELASTIC COAGULATION MONITORING DEVICES
8.7.3.1 ROTATIONAL THROMBOELASTOMETRY (ROTEM)
8.7.3.2 THROMBOELASTOGRAPHY (TEG)
8.8 DRUG-OF-ABUSE (DOA) TESTING PRODUCTS
8.8.1 DOA ANALYSERS
8.8.1.1 IMMUNOASSAYS
8.8.1.2 CHROMATOGRAPHIC DEVICES
8.8.1.3 BREATH ANALYSERS
8.8.2 RAPID TESTING DEVICES
8.8.2.1 URINE TESTING DEVICES
8.8.2.2 ORAL FLUID TESTING DEVICES
8.8.2.3 OTHERS
8.9 URINALYSIS TESTING PRODUCTS
8.9.1 POC URINE STRIP SELF-TESTING
8.9.2 POC URINE TEST STRIP PROFESSIONAL TESTING
8.1 CHOLESTEROL TESTING PRODUCTS
8.10.1 TESTING KITS
8.10.2 INSTRUMENTS
8.10.2.1 TABLE-TOP ANALYZERS
8.10.2.2 HAND-HELD ANALYZERS
8.11 TUMOR/CANCER MARKER TESTING PRODUCTS
8.12 FECAL OCCULT TESTING PRODUCTS
8.12.1 GUAIAC FOB STOOL TEST
8.12.2 LATERAL FLOW IMMUNO-FOB TEST
8.12.3 IMMUNO-FOB AGGLUTINATION TEST
8.12.4 IMMUNO-FOB ELISA TEST
8.13 OTHERS
9 GSA POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE
9.1 OVERVIEW
9.2 OTC TESTING
9.3 PRESCRIPTION-BASED TESTING
10 GSA POINT-OF-CARE TESTING (POCT) MARKET, BY PLATFORM
10.1 OVERVIEW
10.2 LATERAL FLOW ASSAYS/IMMUNOCHROMATOGRAPHY TESTS
10.3 IMMUNOASSAYS
10.4 DIPSTICKS
10.5 MOLECULAR DIAGNOSTICS
10.6 CLINICAL CHEMISTRY ASSAYS
10.7 MICROFLUIDICS
10.8 HEMATOLOGY
10.9 OTHERS
11 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 BLOOD GLUCOSE
11.3 INFECTIOUS DISEASES
11.3.1 COVID-19 TESTING
11.3.2 HIV TESTING
11.3.3 HEPATITIS C TESTING
11.3.4 INFLUENZA TESTING
11.3.5 TUBERCULOSIS TESTING
11.3.6 OTHERS
11.4 VITAL SIGN MONITORING
11.5 CARDIAC MONITORING
11.6 COAGULATION
11.7 HAEMATOLOGY
11.8 NON- INVASIVE SPO2 MONITORING
11.9 BLOOD TRANSFUSION
11.1 NON- INVASIVE PCO2 MONITORING
11.11 WHOLE BLOOD ANALYSIS
11.12 OTHERS
12 GSA POINT-OF-CARE TESTING (POCT) MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS
12.2.1 PRIVATE
12.2.1.1 TIER 1
12.2.1.2 TIER 2
12.2.1.3 TIER 3
12.2.2 PUBLIC
12.3 HOME CARE
12.4 CLINICS
12.5 LABORATORIES
12.6 DIAGNOSTIC CENTERS
12.7 PATHOLOGY LABS
12.8 AMBULATORY SURGERY CENTERS
12.9 ELDERLY CARE CENTERS
12.1 OTHERS
13 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDER
13.3 RETAIL SALES
13.4 ONLINE SALES
13.5 OTHERS
14 BENELUX POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT TYPE
14.1 OVERVIEW
14.2 GLUCOSE MONITORING PRODUCTS
14.2.1 STRIPS
14.2.2 METERS
14.2.3 LANCETS AND LANCING DEVICES
14.3 INFECTIOUS DISEASE TESTING PRODUCTS
14.3.1 COVID-19
14.3.2 HIV TESTING PRODUCTS
14.3.2.1 TESTING REAGENTS
14.3.2.2 TESTING EQUIPMENT
14.3.3 RESPIRATORY INFECTION TESTING PRODUCTS
14.3.4 SEXUALLY TRANSMITTED DISEASES (STD) TESTING
14.3.5 NAAT-BASED SYSTEMS
14.3.6 NON–NAAT-BASED SYSTEMS
14.3.7 HEPATITIS C TESTING PRODUCTS
14.3.7.1 HCV ANTIBODY TESTS
14.3.7.2 HCV VIRAL LOAD TESTS
14.3.8 INFLUENZA TESTING PRODUCTS
14.3.8.1 TRADITIONAL DIAGNOSTIC TEST
14.3.8.1.1 RAPID INFLUENZA DIAGNOSTIC TEST (RIDT)
14.3.8.1.2 DIRECT FLUORESCENT ANTIBODY TEST (DFAT)
14.3.8.1.3 VIRAL CULTURE
14.3.8.1.4 SEROLOGICAL ASSAY
14.3.8.2 MOLECULAR DIAGNOSTIC ASSAY
14.3.8.2.1 RT-PCR
14.3.8.2.2 LOOP-MEDIATED ISOTHERMAL AMPLIFICATION-BASED ASSAY (LAMP)
14.3.8.2.3 NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION TEST (NASBAT)
14.3.8.2.4 SIMPLE AMPLIFICATION-BASED ASSAY (SAMBA)
14.3.9 HEALTHCARE ASSOCIATED INFECTION (HAI) TESTING
14.3.10 TROPICAL DISEASE TESTING PRODUCTS
14.3.11 OTHER INFECTIOUS DISEASE TESTING PRODUCTS
14.4 CARDIOMETABOLIC MONITORING PRODUCTS
14.4.1 CARDIAC MARKER TESTING PRODUCTS
14.4.1.1 HSTNL
14.4.1.2 BNP
14.4.1.3 D-DIMER
14.4.1.4 CK-MB
14.4.1.5 MYOGLOBIN
14.4.2 BLOOD GAS/ELECTROLYTE TESTING PRODUCTS
14.4.3 BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES
14.4.3.1 CARTRIDGES
14.4.3.2 REAGENTS
14.4.4 BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS
14.4.5 PORTABLE
14.4.5.1 COMBINED ANALYZERS
14.4.5.2 BLOOD GAS ANALYZERS
14.4.5.3 ELECTROLYTE ANALYZERS
14.4.6 BENCHTOP
14.4.6.1 COMBINED ANALYZERS
14.4.6.2 BLOOD GAS ANALYZERS
14.4.6.3 ELECTROLYTE ANALYZERS
14.4.7 HBA1C TESTING PRODUCTS
14.4.7.1 HBA1C TESTING INSTRUMENTS
14.4.7.2 HBA1C TESTING CONSUMABLES
14.4.8 POC ANALYZER
14.4.9 ECG DEVICE
14.4.9.1 RESTING ECG DEVICES
14.4.9.2 STRESS ECG DEVICES
14.4.9.3 HOLTER MONITORS
14.5 PREGNANCY AND FERTILITY TESTING PRODUCTS
14.5.1 PREGNANCY TESTING PRODUCTS
14.5.1.1 STRIPS/ DIP STICKS AND CARDS
14.5.1.2 MID STREAM DEVICES
14.5.1.3 CASSETTES
14.5.1.4 DIGITAL DEVICES
14.5.1.5 LINE-INDICATOR DEVICES
14.5.2 FERTILITY TESTING PRODUCTS
14.5.2.1 LUTEINIZING HORMONE (LH) URINE TEST
14.5.2.2 FSH TEST
14.5.2.3 OTHERS
14.6 HAEMATOLOGY TESTING PRODUCTS
14.7 COAGULATION MONITORING PRODUCTS
14.8 ANTICOAGULATION MONITORING DEVICES
14.8.1 PROTHROMBIN TIME/INTERNATIONAL NORMALIZED RATIO (PT-INR) TESTING DEVICES
14.8.2 ACTIVATED CLOTTING TIME (ACT)
14.8.3 ACTIVATED PARTIAL THROMBOPLASTIN TIME (APPT)
14.8.4 PLATELET FUNCTION MONITORING DEVICES
14.8.5 VISCOELASTIC COAGULATION MONITORING DEVICES
14.8.5.1 ROTATIONAL THROMBOELASTOMETRY (ROTEM)
14.8.5.2 THROMBOELASTOGRAPHY (TEG)
14.9 DRUG-OF-ABUSE (DOA) TESTING PRODUCTS
14.9.1 DOA ANALYSERS
14.9.1.1 IMMUNOASSAYS
14.9.1.2 CHROMATOGRAPHIC DEVICES
14.9.1.3 BREATH ANALYSERS
14.9.2 RAPID TESTING DEVICES
14.9.2.1 URINE TESTING DEVICES
14.9.2.2 ORAL FLUID TESTING DEVICES
14.9.3 OTHERS
14.1 URINALYSIS TESTING PRODUCTS
14.10.1 POC URINE STRIP SELF-TESTING
14.10.2 POC URINE TEST STRIP PROFESSIONAL TESTING
14.11 CHOLESTEROL TESTING PRODUCTS
14.11.1 TESTING KITS
14.11.2 INSTRUMENTS
14.11.2.1 TABLE-TOP ANALYZERS
14.11.2.2 HAND-HELD ANALYZERS
14.12 TUMOR/CANCER MARKER TESTING PRODUCTS
14.13 FECAL OCCULT TESTING PRODUCTS
14.13.1 GUAIAC FOB STOOL TEST
14.13.2 LATERAL FLOW IMMUNO-FOB TEST
14.13.3 IMMUNO-FOB AGGLUTINATION TEST
14.13.4 IMMUNO-FOB ELISA TEST
14.14 OTHERS
15 BENELUX POINT-OF-CARE TESTING (POCT) MARKET, BY PLATFORM
15.1 OVERVIEW
15.2 LATERAL FLOW ASSAYS/IMMUNOCHROMATOGRAPHY TESTS
15.3 IMMUNOASSAYS
15.4 DIPSTICKS
15.5 MOLECULAR DIAGNOSTICS
15.6 CLINICAL CHEMISTRY ASSAYS
15.7 MICROFLUIDICS
15.8 HEMATOLOGY
15.9 OTHERS
16 BENELUX POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE
16.1 OVERVIEW
16.2 OTC TESTING
16.3 PRESCRIPTION-BASED TESTING
17 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION
17.1 OVERVIEW
17.2 BLOOD GLUCOSE
17.3 INFECTIOUS DISEASES
17.3.1.1 COVID-19 TESTING
17.3.1.2 HIV TESTING
17.3.1.3 HEPATITIS C TESTING
17.3.1.4 INFLUENZA TESTING
17.3.1.5 TUBERCULOSIS TESTING
17.3.1.6 OTHERS
17.4 VITAL SIGN MONITORING
17.5 CARDIAC MONITORING
17.6 COAGULATION
17.7 HAEMATOLOGY
17.8 NON- INVASIVE SPO2 MONITORING
17.9 BLOOD TRANSFUSION
17.1 NON- INVASIVE PCO2 MONITORING
17.11 WHOLE BLOOD ANALYSIS
17.12 OTHERS
18 BENELUX POINT-OF-CARE TESTING (POCT) MARKET, BY END USER
18.1 OVERVIEW
18.2 HOSPITALS
18.2.1 PRIVATE
18.2.1.1 TIER 1
18.2.1.2 TIER 2
18.2.1.3 TIER 3
18.2.2 PUBLIC
18.3 HOME CARE
18.4 CLINICS
18.5 LABORATORIES
18.6 DIAGNOSTIC CENTERS
18.7 PATHOLOGY LABS
18.8 AMBULATORY SURGERY CENTERS
18.9 ELDERLY CARE CENTERS
18.1 OTHERS
19 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL
19.1 OVERVIEW
19.2 DIRECT TENDER
19.3 RETAIL SALES
19.4 ONLINE SALES
19.5 OTHERS
20 GSA & BENELUX
20.1 GERMANY
20.2 NETHERLANDS
20.3 SWITZERLAND
20.4 BELGIUM
20.5 AUSTRIA
20.6 LUXEMBOURG
21 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: COMPANY LANDSCAPE
21.1 COMPANY SHARE ANALYSIS: GSA AND BENELUX
22 SWOT ANALYSIS
23 COMPANY PROFILE
23.1 F. HOFFMANN-LA ROCHE LTD
23.1.1 COMPANY SNAPSHOT
23.1.2 REVENUE ANALYSIS
23.1.3 PRODUCT PORTFOLIO
23.1.4 RECENT DEVELOPMENT
23.2 DANAHER CORPORATION
23.2.1 COMPANY SNAPSHOT
23.2.2 REVENUE ANALYSIS
23.2.3 PRODUCT PORTFOLIO
23.2.4 RECENT DEVELOPMENT
23.3 SIEMENS HEALTHINEERS AG
23.3.1 COMPANY SNAPSHOT
23.3.2 REVENUE ANALYSIS
23.3.3 PRODUCT PORTFOLIO
23.3.4 RECENT DEVELOPMENT
23.4 BIO- RAD LABORATORIES, INC.
23.4.1 COMPANY SNAPSHOT
23.4.2 REVENUE ANALYSIS
23.4.3 PRODUCT PORTFOLIO
23.4.4 RECENT DEVELOPMENT
23.5 BIOMERIEUX
23.5.1 COMPANY SNAPSHOT
23.5.2 REVENUE ANALYSIS
23.5.3 PRODUCT PORTFOLIO
23.5.4 RECENT DEVELOPMENT
23.6 ACCUBIOTECH CO., LTD.
23.6.1 COMPANY SNAPSHOT
23.6.2 PRODUCT PORTFOLIO
23.6.3 RECENT DEVELOPMENT
23.7 ABBOTT
23.7.1 COMPANY SNAPSHOT
23.7.2 REVENUE ANALYSIS
23.7.3 PRODUCT PORTFOLIO
23.7.4 RECENT DEVELOPMENT/NEWS
23.8 BINX HEALTH
23.8.1 COMPANY SNAPSHOT
23.8.2 SOLUTION PORTFOLIO
23.8.3 RECENT DEVELOPMENT
23.9 BD
23.9.1 COMPANY SNAPSHOT
23.9.2 REVENUE ANALYSIS
23.9.3 PRODUCT PORTFOLIO
23.9.4 RECENT DEVELOPMENT/NEWS
23.1 EKF DIAGNOSTICS HOLDINGS PLC
23.10.1 COMPANY SNAPSHOT
23.10.2 REVENUE ANALYSIS
23.10.3 PRODUCT PORTFOLIO
23.10.4 RECENT DEVELOPMENT
23.11 HOLOGIC, INC
23.11.1 COMPANY SNAPSHOT
23.11.2 REVENUE ANALYSIS
23.11.3 PRODUCT PORTFOLIO
23.11.4 RECENT DEVELOPMENT
23.12 MERIDIAN BIOSCIENCE, INC.
23.12.1 COMPANY SNAPSHOT
23.12.2 PRODUCT PORTFOLIO
23.12.3 RECENT DEVELOPMENT/NEWS
23.13 QIAGEN
23.13.1 COMPANY SNAPSHOT
23.13.2 REVENUE ANALYSIS
23.13.3 PRODUCT PORTFOLIO
23.13.4 RECENT DEVELOPMENT
23.14 QUIDELORTHO CORPORATION
23.14.1 COMPANY SNAPSHOT
23.14.2 REVENUE ANALYSIS
23.14.3 PRODUCT PORTFOLIO
23.14.4 RECENT DEVELOPMENT
23.15 SEKISUI DIAGNOSTICS
23.15.1 COMPANY SNAPSHOT
23.15.2 PRODUCT PORTFOLIO
23.15.3 RECENT DEVELOPMENT
23.16 SYSMEX CORPORATION
23.16.1 COMPANY SNAPSHOT
23.16.2 REVENUE ANALYSIS
23.16.3 PRODUCT PORTFOLIO
23.16.4 RECENT DEVELOPMENT
23.17 SIENCO, INC.
23.17.1 COMPANY SNAPSHOT
23.17.2 PRODUCT PORTFOLIO
23.17.3 RECENT DEVELOPMENT
23.18 TRINITY BIOTECH
23.18.1 COMPANY SNAPSHOT
23.18.2 REVENUE ANALYSIS
23.18.3 PRODUCT PORTFOLIO
23.18.4 RECENT DEVELOPMENT
23.19 THERMO FISHER SCIENTIFIC INC.
23.19.1 COMPANY SNAPSHOT
23.19.2 REVENUE ANALYSIS
23.19.3 PRODUCT PORTFOLIO
23.19.4 RECENT DEVELOPMENT
23.2 WERFEN
23.20.1 COMPANY SNAPSHOT
23.20.2 PRODUCT PORTFOLIO
23.20.3 RECENT DEVELOPMENT
24 QUESTIONNAIRE
表のリスト
TABLE 1 HOME-USE POCT DEVICES WITH TELEMEDICINE INTEGRATION
TABLE 2 COMPANIES AND PRODUCTS WITH TELEMEDICINE INTEGRATION
TABLE 3 A TECHNOLOGY ROADMAP OUTLINING THE FUTURE OF CONNECTED POCT DEVICES
TABLE 4 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 5 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 6 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 7 GSA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 8 GSA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 9 GSA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 10 GSA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 11 GSA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 12 GSA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 13 GSA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 14 GSA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 15 GSA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 16 GSA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 17 GSA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 18 GSA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 19 GSA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 20 GSA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 21 GSA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 22 GSA INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 23 GSA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 24 GSA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 25 GSA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 26 GSA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 27 GSA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 28 GSA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 29 GSA CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 30 GSA POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 31 GSA POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 32 GSA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 33 GSA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 34 GSA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 35 GSA BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 36 GSA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 37 GSA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 38 GSA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 39 GSA BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 40 GSA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 41 GSA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 42 GSA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 43 GSA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 44 GSA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 45 GSA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 46 GSA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 47 GSA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 48 GSA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 49 GSA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 50 GSA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 51 GSA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 52 GSA PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 53 GSA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 54 GSA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 55 GSA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 56 GSA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 57 GSA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 58 GSA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 59 GSA COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 60 GSA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 61 GSA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 62 GSA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 63 GSA VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 64 GSA DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 65 GSA DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 66 GSA DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNIT)
TABLE 67 GSA DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 68 GSA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 69 GSA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 70 GSA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 71 GSA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 72 GSA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 73 GSA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 74 GSA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 75 GSA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 76 GSA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 77 GSA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 78 GSA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 79 GSA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 80 GSA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 81 GSA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 82 GSA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 83 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)
TABLE 84 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)
TABLE 85 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 86 GSA INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 87 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 88 GSA HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 89 GSA PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 90 GSA PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 91 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 92 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 93 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 94 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 95 BENELUX GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 96 BENELUX GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 97 BENELUX GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 98 BENELUX INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 99 BENELUX INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 100 BENELUX INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 101 BENELUX HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 102 BENELUX HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 103 BENELUX HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 104 BENELUX SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 105 BENELUX SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 106 BENELUX SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 107 BENELUX HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 108 BENELUX HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 109 BENELUX HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 110 BENELUX INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 111 BENELUX TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 112 BENELUX TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 113 BENELUX TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 114 BENELUX MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 115 BENELUX MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 116 BENELUX MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 117 BENELUX CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 118 BENELUX POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 119 BENELUX POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 120 BENELUX CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 121 BENELUX CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 122 BENELUX CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 123 BENELUX BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 124 BENELUX BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 125 BENELUX BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 126 BENELUX BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 127 BENELUX BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 128 BENELUX PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 129 BENELUX PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 130 BENELUX PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 131 BENELUX BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 132 BENELUX BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 133 BENELUX BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 134 BENELUX HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 135 BENELUX HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 136 BENELUX HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 137 BENELUX ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 138 BENELUX ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 139 BENELUX ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 140 BENELUX PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 141 BENELUX PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 142 BENELUX PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 143 BENELUX PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 144 BENELUX FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 145 BENELUX FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 146 BENELUX FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 147 BENELUX COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 148 BENELUX ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 149 BENELUX ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 150 BENELUX ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 151 BENELUX VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 152 BENELUX DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 153 BENELUX DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 154 BENELUX DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNIT)
TABLE 155 BENELUX DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 156 BENELUX RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 157 BENELUX RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 158 BENELUX RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 159 BENELUX URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 160 BENELUX URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 161 BENELUX URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 162 BENELUX CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 163 BENELUX CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 164 BENELUX CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 165 BENELUX INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 166 BENELUX INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 167 BENELUX INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 168 BENELUX FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 169 BENELUX FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 170 BENELUX FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 171 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)
TABLE 172 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)
TABLE 173 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 174 BENELUX INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 175 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 176 BENELUX HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 177 BENELUX PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 178 BENELUX PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 179 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 180 GSA & BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)
TABLE 181 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)
TABLE 182 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)
TABLE 183 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 184 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 185 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 186 GERMANY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 187 GERMANY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 188 GERMANY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 189 GERMANY INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 190 GERMANY INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 191 GERMANY INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 192 GERMANY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 193 GERMANY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 194 GERMANY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 195 GERMANY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 196 GERMANY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 197 GERMANY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 198 GERMANY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 199 GERMANY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 200 GERMANY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 201 GERMANY INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 202 GERMANY TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 203 GERMANY TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 204 GERMANY TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 205 GERMANY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 206 GERMANY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 207 GERMANY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 208 GERMANY CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 209 GERMANY POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 210 GERMANY POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 211 GERMANY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 212 GERMANY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 213 GERMANY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 214 GERMANY BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 215 GERMANY BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 216 GERMANY BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 217 GERMANY BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 218 GERMANY BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 219 GERMANY PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 220 GERMANY PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 221 GERMANY PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 222 GERMANY BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 223 GERMANY BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 224 GERMANY BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 225 GERMANY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 226 GERMANY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 227 GERMANY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 228 GERMANY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 229 GERMANY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 230 GERMANY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 231 GERMANY PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 232 GERMANY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 233 GERMANY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 234 GERMANY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 235 GERMANY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 236 GERMANY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 237 GERMANY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 238 GERMANY COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 239 GERMANY ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 240 GERMANY ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 241 GERMANY ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 242 GERMANY VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 243 GERMANY DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 244 GERMANY DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 245 GERMANY DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 246 GERMANY DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 247 GERMANY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 248 GERMANY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 249 GERMANY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 250 GERMANY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 251 GERMANY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 252 GERMANY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 253 GERMANY CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 254 GERMANY CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 255 GERMANY CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 256 GERMANY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 257 GERMANY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 258 GERMANY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 259 GERMANY FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 260 GERMANY FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 261 GERMANY FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 262 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)
TABLE 263 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 264 GERMANY INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 265 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)
TABLE 266 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 267 GERMANY HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 268 GERMANY PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 269 GERMANY PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 270 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 271 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 272 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 273 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 274 NETHERLANDS GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 275 NETHERLANDS GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 276 NETHERLANDS GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 277 NETHERLANDS INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 278 NETHERLANDS INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 279 NETHERLANDS INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 280 NETHERLANDS HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 281 NETHERLANDS HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 282 NETHERLANDS HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 283 NETHERLANDS SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 284 NETHERLANDS SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 285 NETHERLANDS SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 286 NETHERLANDS HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 287 NETHERLANDS HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 288 NETHERLANDS HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 289 NETHERLANDS INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 290 NETHERLANDS TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 291 NETHERLANDS TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 292 NETHERLANDS TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 293 NETHERLANDS MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 294 NETHERLANDS MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 295 NETHERLANDS MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 296 NETHERLANDS CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 297 NETHERLANDS POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 298 NETHERLANDS POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 299 NETHERLANDS CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 300 NETHERLANDS CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 301 NETHERLANDS CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 302 NETHERLANDS BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 303 NETHERLANDS BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 304 NETHERLANDS BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 305 NETHERLANDS BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 306 NETHERLANDS BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 307 NETHERLANDS PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 308 NETHERLANDS PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 309 NETHERLANDS PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 310 NETHERLANDS BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 311 NETHERLANDS BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 312 NETHERLANDS BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 313 NETHERLANDS HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 314 NETHERLANDS HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 315 NETHERLANDS HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 316 NETHERLANDS ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 317 NETHERLANDS ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 318 NETHERLANDS ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 319 NETHERLANDS PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 320 NETHERLANDS PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 321 NETHERLANDS PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 322 NETHERLANDS PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 323 NETHERLANDS FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 324 NETHERLANDS FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 325 NETHERLANDS FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 326 NETHERLANDS COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 327 NETHERLANDS ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 328 NETHERLANDS ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 329 NETHERLANDS ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 330 NETHERLANDS VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 331 NETHERLANDS DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 332 NETHERLANDS DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 333 NETHERLANDS DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 334 NETHERLANDS DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 335 NETHERLANDS RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 336 NETHERLANDS RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 337 NETHERLANDS RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 338 NETHERLANDS URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 339 NETHERLANDS URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 340 NETHERLANDS URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 341 NETHERLANDS CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 342 NETHERLANDS CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 343 NETHERLANDS CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 344 NETHERLANDS INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 345 NETHERLANDS INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 346 NETHERLANDS INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 347 NETHERLANDS FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 348 NETHERLANDS FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 349 NETHERLANDS FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 350 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)
TABLE 351 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 352 NETHERLANDS INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 353 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)
TABLE 354 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 355 NETHERLANDS HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 356 NETHERLANDS PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 357 NETHERLANDS PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 358 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 359 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 360 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 361 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 362 SWITZERLAND GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 363 SWITZERLAND GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 364 SWITZERLAND GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 365 SWITZERLAND INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 366 SWITZERLAND INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 367 SWITZERLAND INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 368 SWITZERLAND HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 369 SWITZERLAND HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 370 SWITZERLAND HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 371 SWITZERLAND SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 372 SWITZERLAND SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 373 SWITZERLAND SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 374 SWITZERLAND HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 375 SWITZERLAND HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 376 SWITZERLAND HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 377 SWITZERLAND INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 378 SWITZERLAND TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 379 SWITZERLAND TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 380 SWITZERLAND TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 381 SWITZERLAND MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 382 SWITZERLAND MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 383 SWITZERLAND MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 384 SWITZERLAND CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 385 SWITZERLAND POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 386 SWITZERLAND POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 387 SWITZERLAND CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 388 SWITZERLAND CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 389 SWITZERLAND CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 390 SWITZERLAND BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 391 SWITZERLAND BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 392 SWITZERLAND BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 393 SWITZERLAND BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 394 SWITZERLAND BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 395 SWITZERLAND PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 396 SWITZERLAND PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 397 SWITZERLAND PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 398 SWITZERLAND BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 399 SWITZERLAND BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 400 SWITZERLAND BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 401 SWITZERLAND HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 402 SWITZERLAND HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 403 SWITZERLAND HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 404 SWITZERLAND ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 405 SWITZERLAND ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 406 SWITZERLAND ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 407 SWITZERLAND PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 408 SWITZERLAND PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 409 SWITZERLAND PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 410 SWITZERLAND PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 411 SWITZERLAND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 412 SWITZERLAND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 413 SWITZERLAND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 414 SWITZERLAND COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 415 SWITZERLAND ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 416 SWITZERLAND ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 417 SWITZERLAND ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 418 SWITZERLAND VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 419 SWITZERLAND DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 420 SWITZERLAND DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 421 SWITZERLAND DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 422 SWITZERLAND DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 423 SWITZERLAND RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 424 SWITZERLAND RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 425 SWITZERLAND RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 426 SWITZERLAND URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 427 SWITZERLAND URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 428 SWITZERLAND URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 429 SWITZERLAND CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 430 SWITZERLAND CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 431 SWITZERLAND CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 432 SWITZERLAND INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 433 SWITZERLAND INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 434 SWITZERLAND INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 435 SWITZERLAND FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 436 SWITZERLAND FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 437 SWITZERLAND FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 438 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)
TABLE 439 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 440 SWITZERLAND INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 441 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)
TABLE 442 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 443 SWITZERLAND HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 444 SWITZERLAND PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 445 SWITZERLAND PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 446 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 447 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 448 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 449 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 450 BELGIUM GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 451 BELGIUM GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 452 BELGIUM GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 453 BELGIUM INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 454 BELGIUM INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 455 BELGIUM INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 456 BELGIUM HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 457 BELGIUM HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 458 BELGIUM HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 459 BELGIUM SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 460 BELGIUM SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 461 BELGIUM SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 462 BELGIUM HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 463 BELGIUM HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 464 BELGIUM HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 465 BELGIUM INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 466 BELGIUM TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 467 BELGIUM TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 468 BELGIUM TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 469 BELGIUM MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 470 BELGIUM MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 471 BELGIUM MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 472 BELGIUM CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 473 BELGIUM POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 474 BELGIUM POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 475 BELGIUM CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 476 BELGIUM CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 477 BELGIUM CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 478 BELGIUM BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 479 BELGIUM BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 480 BELGIUM BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 481 BELGIUM BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 482 BELGIUM BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 483 BELGIUM PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 484 BELGIUM PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 485 BELGIUM PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 486 BELGIUM BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 487 BELGIUM BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 488 BELGIUM BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 489 BELGIUM HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 490 BELGIUM HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 491 BELGIUM HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 492 BELGIUM ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 493 BELGIUM ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 494 BELGIUM ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 495 BELGIUM PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 496 BELGIUM PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 497 BELGIUM PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 498 BELGIUM PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 499 BELGIUM FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 500 BELGIUM FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 501 BELGIUM FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 502 BELGIUM COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 503 BELGIUM ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 504 BELGIUM ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 505 BELGIUM ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 506 BELGIUM VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 507 BELGIUM DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 508 BELGIUM DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 509 BELGIUM DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 510 BELGIUM DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 511 BELGIUM RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 512 BELGIUM RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 513 BELGIUM RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 514 BELGIUM URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 515 BELGIUM URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 516 BELGIUM URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 517 BELGIUM CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 518 BELGIUM CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 519 BELGIUM CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 520 BELGIUM INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 521 BELGIUM INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 522 BELGIUM INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 523 BELGIUM FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 524 BELGIUM FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 525 BELGIUM FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 526 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)
TABLE 527 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 528 BELGIUM INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 529 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)
TABLE 530 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 531 BELGIUM HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 532 BELGIUM PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 533 BELGIUM PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 534 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 535 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 536 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 537 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 538 AUSTRIA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 539 AUSTRIA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 540 AUSTRIA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 541 AUSTRIA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 542 AUSTRIA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 543 AUSTRIA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 544 AUSTRIA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 545 AUSTRIA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 546 AUSTRIA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 547 AUSTRIA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 548 AUSTRIA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 549 AUSTRIA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 550 AUSTRIA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 551 AUSTRIA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 552 AUSTRIA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 553 AUSTRIA INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 554 AUSTRIA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 555 AUSTRIA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 556 AUSTRIA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 557 AUSTRIA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 558 AUSTRIA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 559 AUSTRIA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 560 AUSTRIA CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 561 AUSTRIA POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 562 AUSTRIA POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 563 AUSTRIA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 564 AUSTRIA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 565 AUSTRIA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 566 AUSTRIA BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 567 AUSTRIA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 568 AUSTRIA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 569 AUSTRIA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 570 AUSTRIA BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 571 AUSTRIA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 572 AUSTRIA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 573 AUSTRIA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 574 AUSTRIA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 575 AUSTRIA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 576 AUSTRIA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 577 AUSTRIA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 578 AUSTRIA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 579 AUSTRIA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 580 AUSTRIA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 581 AUSTRIA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 582 AUSTRIA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 583 AUSTRIA PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 584 AUSTRIA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 585 AUSTRIA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 586 AUSTRIA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 587 AUSTRIA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 588 AUSTRIA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 589 AUSTRIA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 590 AUSTRIA COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 591 AUSTRIA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 592 AUSTRIA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 593 AUSTRIA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 594 AUSTRIA VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 595 AUSTRIA DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 596 AUSTRIA DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 597 AUSTRIA DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 598 AUSTRIA DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 599 AUSTRIA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 600 AUSTRIA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 601 AUSTRIA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 602 AUSTRIA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 603 AUSTRIA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 604 AUSTRIA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 605 AUSTRIA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 606 AUSTRIA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 607 AUSTRIA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 608 AUSTRIA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 609 AUSTRIA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 610 AUSTRIA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 611 AUSTRIA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 612 AUSTRIA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 613 AUSTRIA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 614 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)
TABLE 615 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 616 AUSTRIA INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 617 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)
TABLE 618 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 619 AUSTRIA HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 620 AUSTRIA PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 621 AUSTRIA PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 622 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 623 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 624 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 625 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 626 LUXEMBOURG GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 627 LUXEMBOURG GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 628 LUXEMBOURG GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 629 LUXEMBOURG INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 630 LUXEMBOURG INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 631 LUXEMBOURG INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 632 LUXEMBOURG HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 633 LUXEMBOURG HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 634 LUXEMBOURG HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 635 LUXEMBOURG SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 636 LUXEMBOURG SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 637 LUXEMBOURG SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 638 LUXEMBOURG HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 639 LUXEMBOURG HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 640 LUXEMBOURG HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 641 LUXEMBOURG INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 642 LUXEMBOURG TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 643 LUXEMBOURG TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 644 LUXEMBOURG TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 645 LUXEMBOURG MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 646 LUXEMBOURG MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 647 LUXEMBOURG MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 648 LUXEMBOURG CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 649 LUXEMBOURG POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 650 LUXEMBOURG POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 651 LUXEMBOURG CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 652 LUXEMBOURG CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 653 LUXEMBOURG CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 654 LUXEMBOURG BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 655 LUXEMBOURG BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 656 LUXEMBOURG BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 657 LUXEMBOURG BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 658 LUXEMBOURG BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 659 LUXEMBOURG PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 660 LUXEMBOURG PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 661 LUXEMBOURG PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 662 LUXEMBOURG BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 663 LUXEMBOURG BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 664 LUXEMBOURG BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 665 LUXEMBOURG HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 666 LUXEMBOURG HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 667 LUXEMBOURG HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 668 LUXEMBOURG ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 669 LUXEMBOURG ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 670 LUXEMBOURG ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 671 LUXEMBOURG PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 672 LUXEMBOURG PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 673 LUXEMBOURG PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 674 LUXEMBOURG PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 675 LUXEMBOURG FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 676 LUXEMBOURG FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 677 LUXEMBOURG FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 678 LUXEMBOURG COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 679 LUXEMBOURG ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 680 LUXEMBOURG ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 681 LUXEMBOURG ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 682 LUXEMBOURG VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 683 LUXEMBOURG DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 684 LUXEMBOURG DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 685 LUXEMBOURG DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 686 LUXEMBOURG DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 687 LUXEMBOURG RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 688 LUXEMBOURG RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 689 LUXEMBOURG RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 690 LUXEMBOURG URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 691 LUXEMBOURG URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 692 LUXEMBOURG URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 693 LUXEMBOURG CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 694 LUXEMBOURG CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 695 LUXEMBOURG CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 696 LUXEMBOURG INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 697 LUXEMBOURG INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 698 LUXEMBOURG INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 699 LUXEMBOURG FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 700 LUXEMBOURG FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 701 LUXEMBOURG FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 702 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)
TABLE 703 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 704 LUXEMBOURG INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 705 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)
TABLE 706 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 707 LUXEMBOURG HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 708 LUXEMBOURG PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 709 LUXEMBOURG PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 710 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
図表一覧
FIGURE 1 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: SEGMENTATION
FIGURE 2 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: DATA TRIANGULATION
FIGURE 3 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: DROC ANALYSIS
FIGURE 4 GSA POINT-OF-CARE-TESTING (POCT) MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 6 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 7 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: DBMR MARKET POSITION GRID
FIGURE 9 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: MARKET END USER COVERAGE GRID
FIGURE 10 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: SEGMENTATION
FIGURE 11 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE (2024)
FIGURE 12 BEMELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE (2024)
FIGURE 13 GSA POINT-OF-CARE-TESTING (POCT) MARKET: EXECUTIVE SUMMARY
FIGURE 14 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: EXECUTIVE SUMMARY
FIGURE 15 STRATEGIC DECISIONS
FIGURE 16 RISING USE OF POC TESTING IN HEALTHCARE FACILITIES IS EXPECTED TO DRIVE THE GSA POINT-OF-CARE-TESTING (POCT) MARKET, IN THE FORECAST PERIOD OF 2025 TO 2032
FIGURE 17 RISING USE OF POC TESTING IN HEALTHCARE FACILITIES IS EXPECTED TO DRIVE THE BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, IN THE FORECAST PERIOD OF 2025 TO 2032
FIGURE 18 GLUCOSE MONITORING PRODUCTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GSA POINT-OF-CARE-TESTING (POCT) MARKET IN THE FORECAST PERIOD OF 2025 & 2032
FIGURE 19 GLUCOSE MONITORING PRODUCTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE BENELUX POINT-OF-CARE-TESTING (POCT) MARKET IN THE FORECAST PERIOD OF 2025 & 2032
FIGURE 20 DROC ANALYSIS
FIGURE 21 NUMBER OF PEOPLE USING VARIOUS SUBSTANCES OR EXPERIENCING PROBLEMATIC USE PREVALENCE (PERCENTAGE)
FIGURE 22 NUMBER OF PEOPLE USING VARIOUS SUBSTANCES OR EXPERIENCING PROBLEMATIC USE (IN MILLION)
FIGURE 23 SUBSTANCE USE BEHAVIOURS AMONG 15-YEAR-OLDS IN 2022 (SELF-REPORTED PREVALENCE)
FIGURE 24 GSA POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, 2024
FIGURE 25 GSA POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, 2025-2032 (USD THOUSAND)
FIGURE 26 GSA POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, CAGR (2025-2032)
FIGURE 27 GSA POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 28 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, 2024
FIGURE 29 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, 2025 TO 2032 (USD THOUSAND)
FIGURE 30 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, CAGR (2025- 2032)
FIGURE 31 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, LIFELINE CURVE
FIGURE 32 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, 2024
FIGURE 33 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, 2025 TO 2032 (USD THOUSAND)
FIGURE 34 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, CAGR (2025- 2032)
FIGURE 35 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, LIFELINE CURVE
FIGURE 36 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, 2024
FIGURE 37 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, 2025 TO 2032 (USD THOUSAND)
FIGURE 38 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, CAGR (2025- 2032)..
FIGURE 39 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 40 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, 2024
FIGURE 41 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, 2025 TO 2032 (USD THOUSAND)
FIGURE 42 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, CAGR (2025- 2032)
FIGURE 43 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, LIFELINE CURVE
FIGURE 44 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, 2024
FIGURE 45 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, 2025 TO 2032 (USD THOUSAND)
FIGURE 46 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025- 2032)
FIGURE 47 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 48 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, 2024
FIGURE 49 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, 2025-2032 (USD THOUSAND)
FIGURE 50 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, CAGR (2025-2032)
FIGURE 51 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 52 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, 2024
FIGURE 53 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, 2025 TO 2032 (USD THOUSAND)
FIGURE 54 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, CAGR (2025- 2032)
FIGURE 55 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, LIFELINE CURVE
FIGURE 56 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, 2024
FIGURE 57 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, 2025 TO 2032 (USD THOUSAND)
FIGURE 58 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, CAGR (2025- 2032)
FIGURE 59 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, LIFELINE CURVE
FIGURE 60 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, 2024
FIGURE 61 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, 2025 TO 2032 (USD THOUSAND)
FIGURE 62 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, CAGR (2025- 2032)
FIGURE 63 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 64 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, 2024
FIGURE 65 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, 2025 TO 2032 (USD THOUSAND)
FIGURE 66 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, CAGR (2025- 2032)
FIGURE 67 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, LIFELINE CURVE
FIGURE 68 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, 2024
FIGURE 69 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, 2025 TO 2032 (USD THOUSAND)
FIGURE 70 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025- 2032)
FIGURE 71 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 72 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: SNAPSHOT (2024)
FIGURE 73 GSA POINT-OF-CARE-TESTING (POCT) MARKET: SNAPSHOT (2024)
FIGURE 74 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: COMPANY SHARE 2024 (%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
